Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "X"

9431 News Found

Medanta delivers record FY26 performance as revenue surges & profit jumps with expansion
Hospitals | May 18, 2026

Medanta delivers record FY26 performance as revenue surges & profit jumps with expansion

Medanta expanded its bed capacity by 20% during the year


Amrutanjan Healthcare expands portfolio in pain management
News | May 18, 2026

Amrutanjan Healthcare expands portfolio in pain management

Company enters women’s personal grooming segment while strengthening pain management portfolio with herbal Ortho Oil


Surya Hospitals expands advanced women-centric health services
Hospitals | May 18, 2026

Surya Hospitals expands advanced women-centric health services

New facility ‘Amber Wing’ adds 55 beds and strengthens surgical, cardiac, robotic and preventive care infrastructure for women in Mumbai


Shilpa Medicare signs long-term CDMO pact with NXI Therapeutics to expand global biotech push
News | May 14, 2026

Shilpa Medicare signs long-term CDMO pact with NXI Therapeutics to expand global biotech push

Shilpa will deliver end-to-end services including CMC development, process scale-up, GMP clinical supply, and commercial manufacturing support


AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX
interviews | May 13, 2026

AI will eliminate 70-80% of current pharma commercial processes: Dushyant Sapre, Founder and CEO, SwishX

We are building an AI-native operating system for pharma sales and distribution


Industry-academia partnership expands access to advanced life sciences analytics for Indian researchers
News | May 13, 2026

Industry-academia partnership expands access to advanced life sciences analytics for Indian researchers

High-resolution analytical platforms from Agilent Technologies will be made available through C-CAMP’s shared infrastructure model under expanded collaboration


Vyome secures exclusive license from Impetis for selective JAK inhibitor programs
News | May 13, 2026

Vyome secures exclusive license from Impetis for selective JAK inhibitor programs

The global JAK inhibitors market is projected to REACH $56.78 billion by 2030, reflecting strong demand for targeted immunology treatments


FDA okays RIVANNA’s AI-powered Accuro XV ultrasound system
Medical Device | May 12, 2026

FDA okays RIVANNA’s AI-powered Accuro XV ultrasound system

The clearance marks a pivotal step forward for the company as it pushes deeper into AI-driven diagnostics and expands its clinical footprint in point-of-care imaging


SwishX raises $2.2 million seed to launch agentic AI for pharma and MedTech
Digitisation | May 12, 2026

SwishX raises $2.2 million seed to launch agentic AI for pharma and MedTech

Bengaluru startup targets 100+ enterprise clients and global expansion as it aims to transform pharmaceutical sales, marketing, tenders, and distribution using AI agents


Computational tool ‘Renoir’ to decode cell communication in complex tissues
R&D | May 12, 2026

Computational tool ‘Renoir’ to decode cell communication in complex tissues

IIT Kanpur team has developed computational framework to map how cell signals influence gene activity across tissues